New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 29, 2020 - The FDA announced the approval of Genentech’s Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf).
Download PDF
Return to publications
